20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth
Precigen, Inc. Stockholders Approve 2023 Plan Amendment No. 3
Reports First Quarter 2026 Financial Results and Business Updates
Financial Results, Press Release
Unregistered Sales of Equity Securities
Announces Up to $125 Million Non-Dilutive Financing
News, Material Contracts
Q2
Q1
FY 2025
Q3
Amended Annual Report
FY 2024
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload